Berta Jereb

3.1k total citations
100 papers, 2.2k citations indexed

About

Berta Jereb is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Berta Jereb has authored 100 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 22 papers in Molecular Biology and 22 papers in Genetics. Recurrent topics in Berta Jereb's work include Glioma Diagnosis and Treatment (21 papers), Sarcoma Diagnosis and Treatment (19 papers) and Neuroblastoma Research and Treatments (14 papers). Berta Jereb is often cited by papers focused on Glioma Diagnosis and Treatment (21 papers), Sarcoma Diagnosis and Treatment (19 papers) and Neuroblastoma Research and Treatments (14 papers). Berta Jereb collaborates with scholars based in Slovenia, United States and Sweden. Berta Jereb's co-authors include Philip R. Exelby, Fereshteh Ghavimi, Mara Popović, Primož Strojan, Jeffrey C. Allen, Jan Stjernswärd, Lawrence Helson, Alison Reid, Lars Åhström and Bengt Sandstedt and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Berta Jereb

98 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berta Jereb Slovenia 28 760 511 498 481 481 100 2.2k
J E Kingston United Kingdom 27 587 0.8× 677 1.3× 468 0.9× 443 0.9× 325 0.7× 53 2.4k
M Brunat-Mentigny France 30 1.0k 1.4× 498 1.0× 426 0.9× 474 1.0× 611 1.3× 96 2.1k
Jorge A. Ortega United States 18 431 0.6× 367 0.7× 451 0.9× 362 0.8× 411 0.9× 25 1.6k
Maurizio Lestani Italy 26 885 1.2× 604 1.2× 234 0.5× 621 1.3× 455 0.9× 57 2.9k
D Hammond United States 23 861 1.1× 634 1.2× 367 0.7× 472 1.0× 195 0.4× 48 2.3k
Joachim Kühl Germany 24 409 0.5× 438 0.9× 230 0.5× 609 1.3× 1.1k 2.3× 59 2.1k
Abdelsalam H. Ragab United States 28 1.7k 2.3× 909 1.8× 688 1.4× 377 0.8× 285 0.6× 75 2.9k
Martin Benesch Austria 31 643 0.8× 457 0.9× 534 1.1× 931 1.9× 1.2k 2.5× 157 3.4k
Fabrizio Lombardi Italy 13 612 0.8× 749 1.5× 281 0.6× 128 0.3× 428 0.9× 26 1.7k
Bernhard Kremens Germany 36 440 0.6× 784 1.5× 388 0.8× 734 1.5× 391 0.8× 83 3.6k

Countries citing papers authored by Berta Jereb

Since Specialization
Citations

This map shows the geographic impact of Berta Jereb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berta Jereb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berta Jereb more than expected).

Fields of papers citing papers by Berta Jereb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berta Jereb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berta Jereb. The network helps show where Berta Jereb may publish in the future.

Co-authorship network of co-authors of Berta Jereb

This figure shows the co-authorship network connecting the top 25 collaborators of Berta Jereb. A scholar is included among the top collaborators of Berta Jereb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berta Jereb. Berta Jereb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Todorovski, Ljupčo, et al.. (2012). Late somatic sequelae after treatment of childhood cancer in Slovenia. BMC Research Notes. 5(1). 254–254. 5 indexed citations
2.
Perme, Maja Pohar & Berta Jereb. (2009). TRENDS IN SURVIVAL AFTER CHILDHOOD CANCER IN SLOVENIA BETWEEN 1957 AND 2007. Pediatric Hematology and Oncology. 26(4). 240–251. 9 indexed citations
3.
Kržišnik, Ciril, et al.. (2008). Cardiac damage after treatment of childhood cancer: A long-term follow-up. BMC Cancer. 8(1). 141–141. 17 indexed citations
4.
Svetičič, Jerneja, et al.. (2006). Suicidal behaviour in long-term survivors of childhood cancer. Psychiatria Danubina. 18. 39–40. 1 indexed citations
5.
Jereb, Berta, et al.. (2005). PEDIATRIC OSTEOSARCOMA: A 35-Year Experience in Slovenia. Pediatric Hematology and Oncology. 22(4). 335–343. 8 indexed citations
6.
Strojan, Primož, et al.. (2005). The role of radiotherapy in the treatment of childhood intracranial germinoma: Long‐term survival and late effects. Pediatric Blood & Cancer. 47(1). 77–82. 14 indexed citations
7.
Jazbec, Janez, P. Ećimović, & Berta Jereb. (2004). Second neoplasms after treatment of childhood cancer in Slovenia. Pediatric Blood & Cancer. 42(7). 574–581. 25 indexed citations
8.
Jereb, Berta, et al.. (2003). Long-Term Sequelae in Children Treated for Brain Tumors: Impairments, Disability, and Handicap. Pediatric Hematology and Oncology. 20(2). 89–101. 57 indexed citations
9.
Pohar‐Marinšek, Živa, et al.. (2002). Value of fine needle aspiration biopsy in childhood rhabdomyosarcoma: Twenty‐six years of experience in Slovenia. Medical and Pediatric Oncology. 38(6). 416–420. 8 indexed citations
10.
Pohar‐Marinšek, Živa, et al.. (2002). Twenty‐three years of experience in the management of childhood rhabdomyosarcoma in Slovenia. Medical and Pediatric Oncology. 40(2). 118–119. 1 indexed citations
11.
Rakovec, Peter, et al.. (2000). LATE CARDIAC DAMAGE OF ANTHRACYCLINE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDHOOD. Pediatric Hematology and Oncology. 17(7). 527–540. 20 indexed citations
12.
Strojan, Primož, Mara Popović, & Berta Jereb. (2000). Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature. International Journal of Radiation Oncology*Biology*Physics. 48(1). 65–73. 116 indexed citations
13.
Strojan, Primož, et al.. (1997). Combined radiation and chemotherapy for advanced undifferentiated nasopharyngeal carcinoma in children. Medical and Pediatric Oncology. 28(5). 366–369. 13 indexed citations
14.
Jereb, Berta, et al.. (1996). Pediatric Oncology in Slovenia. Pediatric Hematology and Oncology. 13(5). 401–404. 3 indexed citations
15.
Öman, Mikael, et al.. (1991). Human Leukocyte Interferon Alpha (HLI-α) for Treatment of Pleural Effusion Caused by non Small Cell Lung Cancer : A pilot study. Acta Oncologica. 30(8). 963–965. 1 indexed citations
16.
Jereb, Berta, et al.. (1989). Intratumor Application of Human Leukocyte Interferon-α in Patients with Malignant Brain Tumors. American Journal of Clinical Oncology. 12(1). 1–7. 13 indexed citations
17.
Jereb, Berta, et al.. (1987). Intrapleural Application of Human Leukocyte Interferon (HLI) in Breast Cancer Patients with Ipsilateral Pleural Carcinomatosis. Journal of Interferon Research. 7(4). 357–363. 11 indexed citations
18.
Marion, J., M F Tournade, Pierre Bey, et al.. (1986). Abdominal recurrences in Wilms' tumours: A report from the SIOP Wilms' tumour trials and studies. Radiotherapy and Oncology. 5(3). 175–182. 24 indexed citations
19.
Jereb, Berta, et al.. (1986). Redefined Role of Radiation in Combined Treatment of Ewing's Sarcoma. Pediatric Hematology and Oncology. 3(2). 111–118. 11 indexed citations
20.
Jereb, Berta & Gunnar Eklund. (1973). Factors Influencing the Cure Rate in Nephroblastoma: A review of 335 cases. Acta Radiologica Therapy Physics Biology. 12(2). 84–106. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026